Moreover, melatonin is used as a therapeutic agent against obesity [195,196,197], obesity-induced leptin resistance [198,199], diabetes mellitus [200], hepatic steatosis [201], and myocardial injury [202]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.